Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 17, 2006TAXUS benefits demonstrated in non-diabetic patient population carry over into insulin-treated diabetic patients
TAXUS benefits demonstrated in non-diabetic patient population carry over into insulin-treated diabetic patients
-
May 16, 2006
TAXUS VI results support positive safety and efficacy profile
-
May 16, 2006
Boston Scientific's second generation stent compares favorably to market leading TAXUS Express2™ stent system, even with more complex lesions
-
May 16, 2006
Company made the announcement at the annual Paris Course on Revascularization (EuroPCR).
-
May 16, 2006Boston Scientific's second-generation stent system now approved for treatment of acute mycocardial infarction, total occlusions and in-stent restenosis
Boston Scientific's second-generation stent system now approved for treatment of acute mycocardial infarction, total occlusions and in-stent restenosis
-
May 15, 2006
Cardiac Rhythm Management (CRM) Group is formerly Guidant's CRM business; Boston Scientific acquired Guidant on April 21
-
May 11, 2006
Court also upheld its earlier decision dismissing the TAXUS® Liberte™ product from the case, without prejudice
-
May 11, 2006
Pending approval from the Board of Directors, Dr. Baim will also join Boston Scientific's Executive Committee
-
May 10, 2006
Boston Scientific is the exclusive U.S. distributor of this product for a new treatment option for female stress urinary incontinence
-
May 9, 2006
Results to include nine-month data on TAXUS® Liberte™